Xu X - Search Results

1

Long Non-coding RNA SNHG12 Functions as a Competing Endogenous RNA to Regulate MDM4 Expression by Sponging miR-129-5p in Clear Cell Renal Cell Carcinoma.

Wu Z, Chen D, Wang K, Cao C, Xu X. Wu Z, et al. Among authors: xu x. Front Oncol. 2019 Nov 22;9:1260. doi: 10.3389/fonc.2019.01260. eCollection 2019. Front Oncol. 2019. PMID: 31824846 Free PMC article.

2

MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma.

Shi Q, Xu X, Liu Q, Luo F, Shi J, He X. Shi Q, et al. Among authors: xu x. Oncol Lett. 2016 Feb;11(2):1474-1480. doi: 10.3892/ol.2015.4072. Epub 2015 Dec 31. Oncol Lett. 2016. PMID: 26893763 Free PMC article.

3

Prognostic Role of High Gal-9 Expression in Solid Tumours: a Meta-Analysis.

Wang K, Chen Z, Wu R, Yin J, Fan M, Xu X. Wang K, et al. Among authors: xu x. Cell Physiol Biochem. 2018;45(3):993-1002. doi: 10.1159/000487294. Epub 2018 Feb 5. Cell Physiol Biochem. 2018. PMID: 29428936 Free article.

4

Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target.

Chen D, Chen W, Xu Y, Zhu M, Xiao Y, Shen Y, Zhu S, Cao C, Xu X. Chen D, et al. Among authors: xu x, xu y. J Med Genet. 2019 Jan;56(1):43-49. doi: 10.1136/jmedgenet-2018-105454. Epub 2018 Jul 2. J Med Genet. 2019. PMID: 29967134

5

LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.

Chen D, Zhu M, Su H, Chen J, Xu X, Cao C. Chen D, et al. Among authors: xu x. J Cell Physiol. 2019 May;234(5):7257-7265. doi: 10.1002/jcp.27483. Epub 2018 Oct 26. J Cell Physiol. 2019. PMID: 30367453

6

A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma.

Wu Z, Liu J, Sun R, Chen D, Wang K, Cao C, Xu X. Wu Z, et al. Among authors: xu x. Front Genet. 2020 Jan 29;10:1333. doi: 10.3389/fgene.2019.01333. eCollection 2019. Front Genet. 2020. PMID: 32063918 Free PMC article.

7

Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells.

Wang K, Chen Z, Shi J, Feng Y, Yu M, Sun Y, Zhuang Q, Liang B, Luo G, Xu X, Fan M. Wang K, et al. Among authors: xu x. Prostate. 2020 Sep;80(12):977-985. doi: 10.1002/pros.24029. Epub 2020 Jun 15. Prostate. 2020. PMID: 32542727

8

Risk Factors for Postpartum Stress Urinary Incontinence: a Systematic Review and Meta-analysis.

Wang K, Xu X, Jia G, Jiang H. Wang K, et al. Among authors: xu x. Reprod Sci. 2020 Dec;27(12):2129-2145. doi: 10.1007/s43032-020-00254-y. Epub 2020 Jul 7. Reprod Sci. 2020. PMID: 32638282

9

A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.

Wu Z, Shen Y, Fan D, Liu J, Chen D, Wang K, Xu X. Wu Z, et al. Among authors: xu x. Int Immunopharmacol. 2021 Jan;90:107119. doi: 10.1016/j.intimp.2020.107119. Epub 2020 Nov 24. Int Immunopharmacol. 2021. PMID: 33243605

10

Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis.

Wang K, Ge J, Han W, Wang D, Zhao Y, Shen Y, Chen J, Chen D, Wu J, Shen N, Zhu S, Xue B, Xu X. Wang K, et al. Among authors: xu x. BMC Urol. 2022 Apr 19;22(1):62. doi: 10.1186/s12894-022-01017-4. BMC Urol. 2022. PMID: 35439979 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58,263 results

Search Page

Filters